Kiwi Wealth Investments Limited Partnership decreased its stake in Cigna Corporation (NYSE:CI) by 4.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,491 shares of the health services provider’s stock after selling 1,272 shares during the quarter. Kiwi Wealth Investments Limited Partnership’s holdings in Cigna Corporation were worth $5,326,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of CI. Spot Trading L.L.C. increased its position in Cigna Corporation by 108.9% in the first quarter. Spot Trading L.L.C. now owns 1,998 shares of the health services provider’s stock worth $293,000 after buying an additional 24,425 shares in the last quarter. Trust Co. of Vermont boosted its stake in shares of Cigna Corporation by 91.4% in the second quarter. Trust Co. of Vermont now owns 1,137 shares of the health services provider’s stock worth $190,000 after acquiring an additional 543 shares during the period. Creative Planning boosted its stake in shares of Cigna Corporation by 7.8% in the second quarter. Creative Planning now owns 13,269 shares of the health services provider’s stock worth $2,221,000 after acquiring an additional 956 shares during the period. State of Alaska Department of Revenue boosted its stake in shares of Cigna Corporation by 17.8% in the second quarter. State of Alaska Department of Revenue now owns 5,549 shares of the health services provider’s stock worth $928,000 after acquiring an additional 840 shares during the period. Finally, National Pension Service boosted its stake in shares of Cigna Corporation by 8.6% in the second quarter. National Pension Service now owns 210,859 shares of the health services provider’s stock worth $35,150,000 after acquiring an additional 16,704 shares during the period. Institutional investors and hedge funds own 89.69% of the company’s stock.
In other news, Chairman Isaiah Harris, Jr. sold 247 shares of the stock in a transaction that occurred on Tuesday, September 12th. The stock was sold at an average price of $185.27, for a total value of $45,761.69. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Mary T. Hoeltzel sold 575 shares of the stock in a transaction that occurred on Thursday, November 9th. The stock was sold at an average price of $197.03, for a total value of $113,292.25. Following the completion of the sale, the chief accounting officer now owns 2,499 shares in the company, valued at $492,377.97. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 2,054 shares of company stock worth $389,721. Company insiders own 1.30% of the company’s stock.
Shares of Cigna Corporation (NYSE CI) traded down $0.47 during mid-day trading on Wednesday, reaching $197.14. The company’s stock had a trading volume of 1,263,100 shares, compared to its average volume of 1,361,488. Cigna Corporation has a fifty-two week low of $131.03 and a fifty-two week high of $206.45. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.39 and a current ratio of 0.39. The stock has a market capitalization of $48,720.69, a P/E ratio of 19.04, a PEG ratio of 1.51 and a beta of 0.49.
Cigna Corporation (NYSE:CI) last issued its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.36 by $0.47. Cigna Corporation had a return on equity of 18.85% and a net margin of 5.74%. The business had revenue of $10.38 billion for the quarter, compared to the consensus estimate of $10.17 billion. During the same period in the prior year, the business posted $1.94 earnings per share. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. equities research analysts expect that Cigna Corporation will post 10.34 earnings per share for the current fiscal year.
CI has been the subject of a number of recent analyst reports. Zacks Investment Research raised Cigna Corporation from a “hold” rating to a “buy” rating and set a $214.00 price objective for the company in a research note on Monday, October 9th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $191.00 price objective on shares of Cigna Corporation in a research note on Sunday, September 17th. ValuEngine lowered Cigna Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 20th. Jefferies Group LLC upped their price objective on Cigna Corporation from $201.00 to $221.00 and gave the stock a “buy” rating in a research note on Friday, October 13th. Finally, Credit Suisse Group reaffirmed a “buy” rating and issued a $196.00 price objective on shares of Cigna Corporation in a research note on Friday, August 4th. Three investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $201.50.
TRADEMARK VIOLATION WARNING: This article was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://sportsperspectives.com/2017/11/15/kiwi-wealth-investments-limited-partnership-has-5-33-million-holdings-in-cigna-corporation-ci.html.
About Cigna Corporation
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.